CLINICAL_TRIALS
trial_result
· 2021-08-17
Clinical Trial Update: Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis [Phase 4]
Summary
A Phase 4 safety study comparing tofacitinib with a TNF inhibitor in rheumatoid arthritis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Arthritis, Rheumatoid | Phase 4 | Status: COMPLETED | Results posted: 2021-08-17